SCHEMBL664372

SCHEMBL664372

CC(C)(C)[Si](C)(C)OCCCc1ccc(C=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DUT P33316 2/20 0.41
PPARG P37231 3/20 0.37
PPARA Q07869 1/20 0.37
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
CYP2A6 P11509 2/20 0.33
BACE1 P56817 1/20 0.33
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
ALDH1A3 P47895 2/20 0.32
IDO1 P14902 1/20 0.32
ALDH3A1 P30838 1/20 0.32
NR3C1 P04150 1/20 0.32
NR3C2 P08235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2356225 0.91 ALDH1A1 (0.41) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL30840869 0.83 DUT (0.38) ALDH1A1DUTPPARGPPARAIDO1
SCHEMBL17100452 0.82 ALDH1A1 (0.56) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
Acetaldehyde SCHEMBL8696394 0.82 IDO1 (0.46) LMNADUTIDO1KMT2A
SCHEMBL979052 0.81 BACE1 (0.40) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL14183641 0.81 KCNH2 (0.42) LMNADUTCYP2A6IDO1
SCHEMBL410888 0.80 DUT (0.40) ALDH1A1SMN1; SMN2DUTPPARAIDO1
SCHEMBL662532 0.80 DUT (0.40) ALDH1A1LMNASMN1; SMN2DUTPPARG
SCHEMBL14832628 0.80 MAOB (0.43) ALDH1A1MAPTDUTIDO1KMT2A
SCHEMBL30859481 0.80 DUT (0.40) ALDH1A1DUTIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046293-A1 RENIN INHIBITORS MERCK FROSST CANADA LTD. (CA) 2012-02-23 US disclosed
US-8063105-B2 Renin inhibitors MERCK CANADA INC. (CA) 2011-11-22 US disclosed
US-20090281103-A1 Renin Inhibitors MERCK CANADA INC. (CA) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046293-A1 RENIN INHIBITORS REN, ACE, AGTR1 ALDH1A1 2104/4885LMNA 1559/4885MAPT 3436/4885
US-20090281103-A1 Renin Inhibitors REN, ACE, AGT ALDH1A1 2078/4885LMNA 1587/4885MAPT 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.